Corceuticals
Miamisburg · Founded 2010
About Corceuticals
Corrceuticals® is a division of their parent company, Nephroceuticals®, responsible for the development of nutriceuticals for the cardiac patient. Micronutrient deficiency as well as the benefits of specific nutritional support in the form of fish oil and Vitamin D is well documented in patients with heart disease and led to the company’s first product, CARDIAMIN. The Corceuticals® team is comprised of some of the leading experts in Cardiology working together to develop optimal nutritional support based on the latest clinical evidence as well as guidelines put forth by the Heart Failure Society of America and the American Heart Association. The company is committed to education and raising patient awareness about the importance of nutrition, and has formed educational partnerships with some of the nation's leading medical practices and organizations such as the American Association of Heart Failure Nurses and the National Kidney Foundation.
Company Facts
- Founded: 2010
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Estimated revenue: $1K – $10K
- Total funding: $1.1M
- Last round: Series Unknown (Mar 2012)
- Website: https://nephroceuticals.com/core.aspx
- Phone: +1 937-281-0123
Canonical: https://fsome.com/organization/corceuticals-8388277 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.